Fineline Cube

Follow:
14761 Articles
BMS's Breyanzi Approved by EC for Relapsed or Refractory Follicular Lymphoma
CompanyDrug

BMS’s Breyanzi Approved by EC for Relapsed or Refractory Follicular Lymphoma

Accropeutics Closes RMB100 Million Series B+ Round to Advance Inflammatory Disease Pipeline
CompanyDeals

Accropeutics Closes RMB100 Million Series B+ Round to Advance Inflammatory Disease Pipeline

Life Molecular Imaging Launches Neuraceq in Hong Kong for Alzheimer's Detection
CompanyDrug

Life Molecular Imaging Launches Neuraceq in Hong Kong for Alzheimer’s Detection

Frontera Therapeutics Receives NMPA Approval for FT-003 in Diabetic Retinopathy Study
CompanyDrug

Frontera Therapeutics Receives NMPA Approval for FT-003 in Diabetic Retinopathy Study

Inari Medical Wins NMPA Approval for Thrombectomy Stent System in China
CompanyMedical Device

Inari Medical Wins NMPA Approval for Thrombectomy Stent System in China

Jiangsu Hengrui Pharmaceuticals' Tegileridine Approved for Postoperative Pain Management
CompanyDrug

Jiangsu Hengrui Pharmaceuticals’ Tegileridine Approved for Postoperative Pain Management

Doma Biopharmaceutical's HER3-MUC1 Targeted ADC DM002 Receives NMPA Clinical Approval
CompanyDrug

Doma Biopharmaceutical’s HER3-MUC1 Targeted ADC DM002 Receives NMPA Clinical Approval

MicroPort Endovascular MedTech's Cratos System Approved for Aortic Dissection Treatment
CompanyMedical Device

MicroPort Endovascular MedTech’s Cratos System Approved for Aortic Dissection Treatment

Akeso Biopharma's Penpulimab Approved for First-Line NPC Treatment
CompanyDrug

Akeso Biopharma’s Penpulimab Approved for First-Line NPC Treatment

Innovent Biologics' Sycume Approved by China's NMPA for Thyroid Eye Disease
CompanyDrug

Innovent Biologics’ Sycume Approved by China’s NMPA for Thyroid Eye Disease

Simcere Pharmaceutical's ADC189 NDA Accepted for Influenza Treatment
CompanyDrug

Simcere Pharmaceutical’s ADC189 NDA Accepted for Influenza Treatment

Rona Therapeutics Secures $25M Pre-B Round to Advance siRNA Therapies
Company

Rona Therapeutics Secures $25M Pre-B Round to Advance siRNA Therapies